Updated: November 2026

Yes. CAR T-cell therapy is available in Israel for eligible patients with certain blood cancers, including multiple myeloma, some types of B-cell lymphoma and B-cell acute lymphoblastic leukemia (ALL). Israeli hospitals offer different CAR-T treatment programs, including therapies developed and manufactured within the hospitals.

International patients can apply for a medical review. The appropriate hospital and treatment program depend on the diagnosis, previous treatments, current medical condition and the programs accepting patients at the time of application.

Contact us to check your CAR-T treatment options in Israel

Can international patients receive CAR-T therapy in Israel?

Yes. Israeli hospitals consider international patients for CAR-T therapy following an individual medical assessment. However, the availability of CAR-T in Israel does not mean that every patient or every type of cancer is suitable for treatment.

Which Israeli hospitals offer CAR-T therapy?

Sheba Medical Center and Hadassah Medical Center are among the Israeli hospitals offering CAR-T therapy. Their programs differ in the diseases treated, the CAR-T products used and the criteria for accepting patients.

We can help you clarify these options by coordinating an initial medical review and obtaining relevant information about eligibility, treatment arrangements, timing and costs.

Choosing a hospital for CAR-T cell therapy

Why consider Israel for CAR-T therapy?

Israel is home to internationally recognized hospitals offering advanced medical care and experienced specialist teams. Sheba Medical Center ranked seventh in Newsweek and Statista’s World’s Best Hospitals 2026, marking its eighth consecutive year in the world’s top ten. Hadassah Medical Center is also recognized in these international rankings, including for oncology.

Many Israeli doctors complete additional specialist training at leading medical centers abroad. Combined with active medical research and a long history of caring for international patients, this experience makes Israel an established destination for patients seeking specialist treatment.

How can I find out whether CAR-T is available for me?

Send us your medical documents in English or translated into English. We will send them to the relevant hospitals for review by specialist doctors and help you quickly find the most suitable hospital for your case.

Time is precious. Let us help you move your research forward.

A happy day: the PET-CT showed no evidence of disease (2026).
Car-t-cell-therapy-for-multiple-myeloma-patient-testimonials-israel-hadassah.jpg

Further information